Comparison of Proliferation Markers Ki-67 and Phosphohistone-H3 (pHH3) in Ductal Carcinoma In Situ of Breast

被引：0
作者：
Chang, O. H. [1 ]
Kilgore, M. R. [1 ]
Schmidt, R. A. [1 ]
Swanson, P. E. [1 ]
Rendi, M. H. [1 ]
机构：
[1] Univ Washington, Med Ctr, Seattle, WA 98195 USA
来源：
LABORATORY INVESTIGATION | 2014年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
2126
引用
收藏
页码：520A / 520A
页数：1
相关论文
共 50 条
  • [41] Correlation of Ki-67, Mitotic Count, and PHH3 in Grading Gastrointestinal and Pancreatic Neuroendocrine Neoplasms
    Popanicolau-Sengos, A.
    Murphy, C. E.
    McCormick, K. A.
    Upton, M. P.
    Shankaran, V.
    Westerhoff, M.
    MODERN PATHOLOGY, 2014, 27 : 197A - 197A
  • [42] Computerized image analysis of Ki-67 in ductal breast carcinoma in situ
    Menter, DG
    Hoque, A
    Motiwala, N
    Sahin, AA
    Sneige, N
    Lieberman, R
    Lippman, SM
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 2001, 23 (03): : 218 - 228
  • [43] Improving mitotic cell counting accuracy and efficiency using phosphohistone-H3 (PHH3) antibody counterstained with haematoxylin and eosin as part of breast cancer grading
    Ibrahim, Asmaa
    Toss, Michael S.
    Makhlouf, Shorouk
    Miligy, Islam M.
    Minhas, Fayyaz
    Rakha, Emad A.
    HISTOPATHOLOGY, 2023, 82 (03) : 393 - 406
  • [44] Phosphohistone H3 (PHH3) Is a Reliable Proliferation Marker in Grading Pulmonary and Pancreatogastrointestinal Neuronendocrine Neoplasms
    Zhou, W.
    Balakrishna, J.
    Ghali, V.
    LABORATORY INVESTIGATION, 2014, 94 : 161A - 161A
  • [45] Phosphohistone 3 (PHH3) in breast cancer: clinical utility and predictive/prognostic value
    Faragalla, Hala
    Jakate, Kiran
    Nagaria, Teddy
    Ibrahim, Luke
    MODERN PATHOLOGY, 2018, 31 : 59 - 59
  • [46] Phosphohistone H3 (PHH3) Is a Reliable Proliferation Marker in Grading Pulmonary and Pancreatogastrointestinal Neuronendocrine Neoplasms
    Zhou, W.
    Balakrishna, J.
    Ghali, V.
    MODERN PATHOLOGY, 2014, 27 : 161A - 161A
  • [47] STAT3 Expression and Correlation Between Ki-67 and PHH3 in Meningiomas: Is it Possible to Predict Recurrence?
    Coskun, Sinem Kantarcioglu
    Kilic, Guven
    DUZCE MEDICAL JOURNAL, 2022, 24 (02) : 201 - 206
  • [48] Phosphohistone 3 (PHH3) in breast cancer: clinical utility and predictive/prognostic value
    Faragalla, Hala
    Jakate, Kiran
    Nagaria, Teddy
    Ibrahim, Luke
    LABORATORY INVESTIGATION, 2018, 98 : 59 - 59
  • [49] Prognostic relevance of proliferation markers (Ki-67, PHH3) within the cross-relation of ERG translocation and androgen receptor expression in prostate cancer
    Goltz, Diane
    Montani, Matteo
    Braun, Martin
    Perner, Sven
    Wernert, Nicolas
    Jung, Klaus
    Dietel, Manfred
    Stephan, Carsten
    Kristiansen, Glen
    PATHOLOGY, 2015, 47 (07) : 629 - 636
  • [50] Phosphohistone-H3 and Ki67: Useful Markers in Differentiating Dermatofibroma From Dermatofibrosarcoma Protuberans and Atypical Fibrohistiocytic Lesions
    Agarwal, Atin
    Gopinath, Arun
    Tetzlaff, Michael T.
    Prieto, Victor G.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2017, 39 (07) : 504 - 507
12345